Understanding the Relationship between Gross Alpha/Beta and Radionuclide-Specific Testing in Drinking Water. [PDF]
Ko R, Desrosiers M, Skierszkan E.
europepmc +1 more source
Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years. [PDF]
Zhang J, Mensel B, Baum RP.
europepmc +1 more source
Quantitative gas-phase separation of carrier-free thallium radioisotopes from proton-irradiated nat HgO. [PDF]
Wilson JM +5 more
europepmc +1 more source
Using Natural Isotopes for the Environmental Tracking of a Controlled Landfill Site for Non-Hazardous Waste in Liguria, Italy. [PDF]
Izzotti A +7 more
europepmc +1 more source
Correction: Combinations of treatments based on radiotherapy or radionuclides to enhance immunotherapy efficacy in advanced prostate cancer: a systematic review. [PDF]
Rosenfeld R +9 more
europepmc +1 more source
SALT OVERLY SENSITIVE 1 Na<sup>+</sup>/H<sup>+</sup> Exchanger Operates in Mature Root Zone and Is a Major Contributor to Root Na<sup>+</sup> Exclusion During Shoot-to-Root Na<sup>+</sup> Recirculation. [PDF]
Nagata T +9 more
europepmc +1 more source
Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in mice. [PDF]
Kerr CP +25 more
europepmc +1 more source
Single 0.9-mg intramuscular rhTSH dose achieves target TSH levels in differentiated thyroid carcinoma. [PDF]
Leite PHF, Pires MC, Penna GC.
europepmc +1 more source
Anticancer potential of radioactively activated zinc: mechanisms and therapeutic applications. [PDF]
Kalındemirtaş FD +3 more
europepmc +1 more source
The use of radiopharmaceuticals in targeted cancer therapy: a narrative review. [PDF]
Khalaji A +6 more
europepmc +1 more source

